Gastrointestinal bleeding and warfarin

被引：0
|
作者：
Eadala, P. [1 ]
Crimmins, R. [1 ]
Dolwani, S. [1 ]
Swift, G. L. [1 ]
Green, J. T. [1 ]
机构：
[1] Llandough Hosp, Dept Gastroenterol, Cardiff, S Glam, Wales
来源：
GUT | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
150
引用
收藏
页码：A57 / A58
页数：2
相关论文
共 50 条
  • [21] A new model (Alfalfa-Warfarin-GIB) for predicting the risk of major gastrointestinal bleeding in warfarin patients
    Wu, Shuyi
    Lv, Meina
    Ma, Fuxin
    Feilong, Zhang
    Fang, Guanhua
    Zhang, Jinhua
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (09) : 1195 - 1204
  • [22] A new model (Alfalfa-Warfarin-GIB) for predicting the risk of major gastrointestinal bleeding in warfarin patients
    Shuyi Wu
    Meina Lv
    Fuxin Ma
    Zhang Feilong
    Guanhua Fang
    Jinhua Zhang
    European Journal of Clinical Pharmacology, 2023, 79 : 1195 - 1204
  • [23] Risks of Recurrent Bleeding in Patients Hospitalized With Gastrointestinal Bleeding While on Warfarin vs Direct Oral Anticoagulants
    Tapaskar, Natalie
    Ham, Sandra A.
    Sengupta, Neil
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S338 - S338
  • [24] Our 5 Year Experience with the Risk of Gastrointestinal Bleeding in Dabigatran Compared to Warfarin
    Jiang, Chunsu
    Sherid, Muhammed
    Sayed, Amer
    Lee, Jai Eun
    Bhagatwala, Jigar
    Patel, Harsh
    Oh, Sun Jung
    Sridhar, Subbaramiah
    Sifuentes, Humberto
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : AB280 - AB281
  • [25] Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran
    Kolb, Jennifer M.
    Flack, Kathryn Friedman
    Chatterjee-Murphy, Prapti
    Desai, Jay
    Wallentin, Lars C.
    Ezekowitz, Michael
    Connolly, Stuart
    Reilly, Paul
    Brueckmann, Martina
    Ilgenfritz, John
    Aisenberg, James
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (07) : 1878 - 1889
  • [26] Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran
    Jennifer M. Kolb
    Kathryn Friedman Flack
    Prapti Chatterjee-Murphy
    Jay Desai
    Lars C. Wallentin
    Michael Ezekowitz
    Stuart Connolly
    Paul Reilly
    Martina Brueckmann
    John Ilgenfritz
    James Aisenberg
    Digestive Diseases and Sciences, 2018, 63 : 1878 - 1889
  • [27] IMPACT OF GENETIC FACTORS ON GASTROINTESTINAL BLEEDING IN A PROSPECTIVE COHORT OF NEW WARFARIN USERS
    Dumas, S.
    Perreault, S.
    Cote, R.
    Shahabi, P.
    Mongrain, I
    Gaulin, M.
    Provost, S.
    Tardif, J.
    Dube, M.
    VALUE IN HEALTH, 2015, 18 (07) : A381 - A381
  • [28] Suboptimal resumption of warfarin in octogenarians with atrial fibrillation that develop gastrointestinal bleeding.
    Alirhayim, Z.
    Qureshi, S.
    Khalid, F.
    Patsias, I.
    Elbatta, M.
    Hassan, M.
    Joseph, N.
    Qureshi, W.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 : S192 - S192
  • [29] Concomitant PPI administration reduces risk of upper gastrointestinal bleeding in patients on Warfarin
    Ellrichmann M.
    Der Gastroenterologe, 2017, 12 (2): : 150 - 151
  • [30] Warfarin With Fluoroquinolones, Sulfonamides, or Azole Antifungals: Interactions and the Risk of Hospitalization for Gastrointestinal Bleeding
    Schelleman, H.
    Bilker, W. B.
    Brensinger, C. M.
    Han, X.
    Kimmel, S. E.
    Hennessy, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (05) : 581 - 588
12345